Search

Computer models suggest breast cancer screening guidelines for people with mutations in the genes ATM, CHEK2, and PALB2.

… Thursday, February 17, 2022 Many people have heard of mutations in the BRCA1 and BRCA2 genes that are linked to an increased risk of certain cancers, including breast cancer . But there are other, less well-known genes in which hereditary mutations can also increase breast cancer risk, including ATM

This resource from Amgen® provides information about the on-body injector for Neulasta (pegfilgrastim) injection.

… This resource from Amgen ® provides information about the on-body injector for Neulasta (pegfilgrastim) injection. To view an interactive version of this resource, please visit www.pi.amgen.com/united_states/neulasta/neulasta_dtc . To view a printable version of this resource, please click “ View and

… Job Title Graduate Student Email [email protected] Lab Phone 646-888-3237

Learn about the clinical research we are pursuing on pituitary tumors and clinical trials we are running.

… The Multidisciplinary Pituitary & Skull Base Tumor Center at Memorial Sloan Kettering is involved in a number of clinical trials investigating new medical therapies for patients with Cushing’s disease and acromegaly. These clinical trials give Cushing’s and acromegaly patients access to emerging medications

Get the latest news from MSK about treatments, research, and support for patients and caregivers.

… Get the latest news from MSK about treatments, research, and support for patients and caregivers. MSK Now emails include:  Stories about patients and how they were cared for at MSK The latest scientific discoveries by MSK researchers driving progress in cancer treatment MSK experts’ guidance about trends

… Job Title Memorial Sloan Kettering RO PGY5 Degree MD

MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein.

… Wednesday, May 24, 2017 Summary MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein. KRas is linked to nearly 30% of all cancers. Drug development is a complicated task. In the era of targeted therapies for cancer, medicinal chemists seek to design

Physician-scientist Prasad S. Adusumilli studies tumor immunology and the development of T-cell‒mediated immunotherapy for thoracic malignancies and pleural-based diseases.

… Research led by Prasad S. Adusumilli focuses on investigation of the tumor immune microenvironment and the development of T-cell‒mediated immunotherapy for thoracic malignancies and pleural-based diseases. His team has championed regional immunotherapy delivery strategies, resulting in translation of

Surgeons at Memorial Sloan Kettering were able to remove Dave’s liposarcoma that had been deemed inoperable elsewhere.

… Hear from Our Patients Dave’s Story By Memorial Sloan Kettering Editorial Staff After he found a hard spot in his abdomen that wouldn’t go away, 47-year-old Dave was diagnosed with a liposarcoma, a cancer of the fat tissue that usually begins in the arms, legs, or body cavities. With surgery deemed impossible

Associate Attending Computer Scientist Harini Veeraraghavan's lab develops and translates new AI and machine learning tools diagnosing and personalizing cancer treatments through automated segmentation of normal tissues and tumors applied to radiation treatment automation, early predicting treatment response and toxicity prediction, and longitudinal tumor treatment response monitoring from medical images.

… Associate Attending Computer Scientist Harini Veeraraghavan’s lab develops and translates new AI and machine learning tools diagnosing and personalizing cancer treatments through automated segmentation of normal tissues and tumors applied to radiation treatment automation, early predicting treatment